Clinical trial

Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous…

NCT00343213 · University Hospital, Strasbourg, France, Other · Unknown status

Key facts

NCT number NCT00343213
Title Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix.
Official title Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix. Immunohistochemical Study on Biopsies (Retrospective and Prospective Analysis) and on Liquid Based (SurePath) Cervical Cytology (Prospective Analysis). Correlation With HPV Typing and…
Lead sponsor University Hospital, Strasbourg, France, Other
Status Unknown status
Study type Interventional
Conditions Cervical Intraepithelial Neoplasia Grade 1 (CIN 1)
Intervention type Procedure
Interventions colposcopy
Enrollment 300
Start date Jun 1, 2006
First posted Jun 22, 2006
Last update posted Aug 30, 2011
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies